14 July 2014 by Marlene Rabinovitch

Harnessing Pathology of Pulmonary Hypertension to Therapeutic Advantage

All credits to Marlene Rabinovitch FPVRI, Professor of Pediatrics, at Stanford University School of Medicine, in Stanford- California | United States

Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA

 

Additional key-words:  endothelin receptor antagonists,BMPR2,PPARgamma,p53

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg